Abstract submission closed on Monday, April 6. Please click here if you have any questions.
EAC will showcase abstract presentations from allergists, immunologists, and fellows-in-training. We invite you to participate by submitting your clinical research for review by our Abstract Committee. When preparing your abstract, please organize it into a statement of purpose, methods, and a summary of results, with sufficient detail to support your conclusions.
If your abstract is accepted for the conference, you will be assigned a specific day (Friday or Saturday) to present your findings.
All abstracts will have the option to be published in Allergy & Asthma Proceedings
Abstract Submission Deadline
Monday, April 6, 2026
Abstract Fees
Non-commercial - submission only: no fee
Non-commercial - submission plus publication: no fee
Commercially funded - submission only: $500
Commercially funded - submission plus publication: $1,000
Abstract Instructions
- A structured abstract format is required:
o Title
o Authors
o Introduction (background and purpose of the project/study)
o Methods (study design, techniques)
o Results (summary of data)
o Conclusions
o Funding, if appropriate
- The abstract title should fully reflect the content of the abstract body.
- The abstract must adequately describe the objectives, methods, results, and conclusions to allow the Abstract Committee to evaluate the quality of the work and the proposed presentation.
- Authors should be listed by first name, last name, and highest degree (e.g., John Smith, MD). Affiliations should not be included, as they will not be printed in the program guide; however, they may be included in the final poster presentation.
- Illustrations and tables will not be printed in the program guide but may be included in the presentation poster.
- Supplementary data is not accepted under any circumstances.
- Abbreviations may be used in the abstract, provided they are defined at first mention.
- Abstract length is limited to 300 words.
- Abstracts must be submitted in a word.DOC format.
- Use font New Times Roman, size 12
- Only use bold for title and headings
- Size for poster display: 4 feet high by 6 feet long
- Authors are encouraged, but not required, to submit full-length manuscripts derived from the submitted abstract for peer review and publication.
- Each abstract submission must designate a corresponding author, who will be copied on all correspondence related to the abstract.
- Encore abstracts are permitted.
- The presenter of each accepted abstract does not need to be the author, however the presenter must register for EAC.
- Wherever possible, non-commercial (generic) names should be used in all abstracts and posters. To ensure compliance with this ACCME requirement, the Abstract Committee may request a revised submission.
- All authors must disclose any non–FDA-approved use of FDA-approved drugs in the submission email only. No further disclosure is required.
- Authors must accept sole responsibility for the statements made in their submitted abstract.